- CKUN - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: June 16, 2013
Sorry, there aren't any companies.
- SIC #
|Ticker||Exchange||SIC #||Website||Latest Ticker|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for
The Special Committee of China Shenghuo Pharmaceutical Accepts Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.16 per Share to Be Effected Through a Reverse Stock Split - Apr 16th, 2013 6:00 am
China Shenghuo Pharmaceutical Reports Unaudited Financial Results for the Full Year 2012 - Mar 25th, 2013 6:00 am
China Biotech In Review: Amgen To Build China Presence With Partnerships / M&A - Feb 16th, 2013 11:31 pm
China Shenghuo Pharmaceutical Announces Receipt of Non-Binding Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.15 per Share - Feb 15th, 2013 6:00 am
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financi - May 31st, 2012 8:37 am
View All Current Headlines >>